161 related articles for article (PubMed ID: 36312659)
1. Role of Prophylactic Steroids in Differentiation Syndrome.
Sultana J; Dutta J; Mustarin S; Dey P; Roy A; Mamoon MY
Cureus; 2022 Sep; 14(9):e29531. PubMed ID: 36312659
[TBL] [Abstract][Full Text] [Related]
2. Differentiation Syndrome, a Side Effect From the Therapy of Acute Promyelocytic Leukemia.
Reyhanoglu G; Hughes B; King KE; Cambridge R
Cureus; 2020 Dec; 12(12):e12042. PubMed ID: 33447473
[TBL] [Abstract][Full Text] [Related]
3. A Race Against Time: Early-Onset Differentiation Syndrome Following All-Trans-Retinoic-Acid (ATRA) Therapy in Acute Promyelocytic Leukemia (AML-M3).
Ahmad K; Saleh M; Ali Y; Yaseen A; Ali M; Kakakhel M; Hayat MA
Cureus; 2023 Dec; 15(12):e50042. PubMed ID: 38186512
[TBL] [Abstract][Full Text] [Related]
4. Differentiation syndrome in acute promyelocytic leukaemia.
Stahl M; Tallman MS
Br J Haematol; 2019 Oct; 187(2):157-162. PubMed ID: 31410848
[TBL] [Abstract][Full Text] [Related]
5. The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
LaBella D; Regan S; Konig H; Egan DN; Bailey NA; Mawad R; Gilbert M; Pagel JM; Pu JJ
Front Oncol; 2022; 12():911745. PubMed ID: 35992790
[TBL] [Abstract][Full Text] [Related]
6. Differentiation Syndrome with Severe Abdominal Pain During Induction Treatment of Acute Promyelocytic Leukemia: A Case Report.
Yan H; He D; Huang W; Chen F; He J; Cai Z; Zhao Y
J Pain Res; 2021; 14():1981-1984. PubMed ID: 34234544
[TBL] [Abstract][Full Text] [Related]
7. Differentiation syndrome in patients with acute promyelocytic leukemia.
Rogers JE; Yang D
J Oncol Pharm Pract; 2012 Mar; 18(1):109-14. PubMed ID: 21364078
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia with isochromosome 17q and cryptic PML-RARA successfully treated with all-trans retinoic acid and arsenic trioxide.
Shepshelovich D; Oniashvili N; Parnes D; Klein A; Muchtar E; Yeshaya J; Aviram A; Rabizadeh E; Raanani P
Cancer Genet; 2015 Nov; 208(11):575-9. PubMed ID: 26471811
[TBL] [Abstract][Full Text] [Related]
9. High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol.
Kapoor J; Mirgh SP; Agrawal N; Khushoo V; Tejwani N; Singh R; Mehta P; Bhurani D; Ahmed R
Indian J Hematol Blood Transfus; 2022 Apr; 38(2):394-402. PubMed ID: 35496975
[TBL] [Abstract][Full Text] [Related]
10. Three-Way Translocation t(12;15;17) (p13;q24;q21) Found in Acute Promyelocytic Leukemia with Basophilic Differentiation.
Frazzetto S; Gullo L; Sapuppo G; Fazio M; Lo Faro C; Giunta G; Caravotta I; Mauro E; Parisi MS; Triolo AM; Parrinello NL; Consoli ML; També L; Cambria D; Marino S; Scuderi G; Di Raimondo F
Hematol Rep; 2024 Jun; 16(2):367-374. PubMed ID: 38921185
[TBL] [Abstract][Full Text] [Related]
11. Src family kinase inhibitor PP2 enhances differentiation of acute promyelocytic leukemia cell line induced by combination of all-trans-retinoic acid and arsenic trioxide.
Jung YS; Cheong HJ; Kim SJ; Kim KH; Lee N; Park HS; Won JH
Leuk Res; 2014 Aug; 38(8):977-82. PubMed ID: 24953245
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
13. [Acute promyelocytic leukemia: state-of-the-art management].
Asou N
Rinsho Ketsueki; 2018; 59(6):725-734. PubMed ID: 29973452
[TBL] [Abstract][Full Text] [Related]
14. Fatal Differentiation Syndrome Complicating Acute Promyelocytic Leukemia Treatment: A Case Report.
Khizer U; Annam B; Akhtar A; Dhaliwal JS; Yang C
Cureus; 2024 Feb; 16(2):e54491. PubMed ID: 38516455
[TBL] [Abstract][Full Text] [Related]
15. Treatment related acute promyelocytic leukemia (t-APML) in breast cancer survivor treated with anthracycline based chemotherapy: rare case report.
Madabhavi I; Modi G; Panchal H; Patel A; Anand A; Parikh S
Int J Hematol Oncol Stem Cell Res; 2015 Oct; 9(4):215-7. PubMed ID: 26865933
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
17. Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line.
Yoon SG; Cheong HJ; Kim SJ; Kim KH; Lee SC; Lee N; Park HS; Won JH
Cancer Res Treat; 2013 Jun; 45(2):126-33. PubMed ID: 23864846
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal abnormality of acute promyelocytic leukemia other than
Imataki O; Uemura M
BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
[TBL] [Abstract][Full Text] [Related]
19. All-trans retinoic acid and arsenic trioxide fail to derepress the monocytic differentiation driver Irf8 in acute promyelocytic leukemia cells.
Liu X; Chen J; Yu S; Yan L; Guo H; Dai J; Zhang W; Zhu J
Cell Death Dis; 2017 May; 8(5):e2782. PubMed ID: 28492552
[TBL] [Abstract][Full Text] [Related]
20. A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
Corey SJ; Locker J; Oliveri DR; Shekhter-Levin S; Redner RL; Penchansky L; Gollin SM
Leukemia; 1994 Aug; 8(8):1350-3. PubMed ID: 8057672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
